Skip to content
The Policy VaultThe Policy Vault

Vosevi (sofosbuvir/velpatasvir/voxilaprevir)Medica

Patient already started on Vosevi and needs completion of therapy for an approved indication

Initial criteria

  • Patient has been started on Vosevi for an indication listed in this policy
  • Approve remaining duration to complete a 12-week course of therapy

Approval duration

remainder of 12-week course